28 August 2018
Six more drugs are in the final stage of clinical trials, Veronika Skvortsova, Minister of Health of the Russian Federation said at a briefing.
“In September this year the new antiepileptic medicines will receive registration, there are only six of them, but taking into account the different pharmaceutical forms and different strengths, respectively, more than ten,” said the Minister.
According to the Minister, six antiepileptic drugs in non-invasive forms are in the stage of clinical trials.
“These clinical studies are already at the stage of completion,” Mrs. Skvortsova added.
The Minister recalled that in 2012, only 53 antiepileptic medicines were registered on the territory of the country, and 25 of them were made in Russia.
“To date, in 2018 – 212, that is 4 times more. Including 115 Russian, this is already 54%,” said Mrs. Skvortsova
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024